JoAnn Lim

The University of Texas MD Anderson Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial”.

Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial

Journal of Immunotherapy and Precision Oncology(2025)10.36401/jipo-24-17

N/A

0.217DataRank · unranked

3 citations

Mohamed A. Gouda, Matthew J. Reilley, Amadeo B. Biter, JoAnn Lim, Stacie A. Bean +15 more

Lefitolimod (TLR agonist) and ipilimumab in patients with advanced solid tumors: A phase I trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2564

N/A

0DataRank · unranked

4 citations

Matthew J. Reilley, Amadeo B. Biter, JoAnn Lim, Stacie A. Bean, Ly M. Nguyen +14 more